SGLT2 inhibitors × glycemic control

SynthesisJournal of diabetes investigation2016

Efficacy of canagliflozin combined with antidiabetic drugs in treating type 2 diabetes mellitus: Meta-analysis of randomized control trials.

Qi Meng et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedrandomised · 4,670 people · 2016

Randomised comparison

Lowered glycemic control

−0.60percentage points−0.67 to −0.54

As reported

difference −0.60 %, 95% CI −0.67 to −0.54

One number in the abstract

the abstract, start to end

changes in glycosylated hemoglobin were -0.60% (95% confidence interval -0.67

← favours treatmentfavours comparator →
could be chance
Glycemic control
−0.60−0.67 to −0.54
SGLT2 inhibitorsGlycemic control

SGLT2 inhibitors × glycemic controlhelps?replicated

unlikelylikely
0.92not counted
← favours treatmentfavours comparator →
more certainless certain
1 / 5

3 papers cite it

2016
2017
2018
2019
2020
2021
2022
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27330722